Boehringer Ingelheim
For Healthcare Professionals
x

Registration Form

Required.

Information you provide when registering will be shared with the account owner and host and can be used and shared by them in accordance with their Terms and Privacy Policy.

This webinar is for Health Care Professionals only. Upon submitting this registration, I am confirming that I am a Health Care Professional.

thumbnail

 Document ID: PC-SG-101262

 Speaker: Prof John Wen-Cheng Chang 

6th SSO ASM Lung  Track – Afatinib for the  Treatment of NSCLC with Uncommon EGFR Mutations

Listen to Dr John Wen-Cheng CHANG talk about current and next-generation EGFR-TKIs and their efficacy (ORR, PFS) against uncommon EGFR mutations such as Gly719Xaa, Leu861Gln, and Ser768Ile.

Speaker

Dr_John-wen-cheng-chang
John Wen-Cheng Chang, MD

Attending Physician, Associate Professor
Division of Hematology-Oncology, Department of Internal Medicine,
Chang Gung Memorial Hospital-Linkou Branch
Taoyuan, Taiwan

MORE VIDEOS